Long-term outcomes in pulmonary arterial hypertension in the first-line epoprostenol or first-line bosentan era
- 31 October 2010
- journal article
- Published by Elsevier BV in The Journal of Heart and Lung Transplantation
- Vol. 29 (10), 1150-1158
- https://doi.org/10.1016/j.healun.2010.05.011
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Updated Clinical Classification of Pulmonary HypertensionJournal of the American College of Cardiology, 2009
- Medical Therapy for Pulmonary Arterial HypertensionSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2007
- Long-term outcome with first-line bosentan therapy in idiopathic pulmonary arterial hypertensionEuropean Heart Journal, 2006
- Survival in patients with class III idiopathic pulmonary arterial hypertension treated with first line oral bosentan compared with an historical cohort of patients started on intravenous epoprostenolThorax, 2005
- Survival with first-line bosentan in patients with primary pulmonary hypertensionEuropean Respiratory Journal, 2005
- Survival in Primary Pulmonary HypertensionCirculation, 2002
- Primary Pulmonary Hypertension In IsraelSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2001
- Appetite-Suppressant Drugs and the Risk of Primary Pulmonary HypertensionThe New England Journal of Medicine, 1996
- The International Primary Pulmonary Hypertension Study (IPPHS)Social psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 1994
- Survival in Patients with Primary Pulmonary HypertensionAnnals of Internal Medicine, 1991